Pathophysiology and management of the serotonin syndrome.
OBJECTIVE
To review the symptoms, pathophysiology, and treatment of the serotonin syndrome (SS).


METHODS
A MEDLINE search (1957-1995) of the English-language literature pertaining to the SS was performed. Additional literature was obtained from reference lists of pertinent articles identified through the search.


METHODS
All articles were considered for possible inclusion in the review. Pertinent information, as judged by the authors, was selected for discussion.


RESULTS
The SS, an occasionally fatal disorder, is characterized by symptoms such as mental status changes, seizures, myoclonus, and blood dyscrasias. Both the central and peripheral serotonergic systems and several serotonin receptor types are involved in the symptomatology of the SS. The pathogenesis of SS may be due to endogenous as well as iatrogenic deficits in peripheral serotonin metabolism, a stimulus for release of serotonin, and interactions with other neurotransmitter systems. Lorazepam, serotonin-blockers, and nitroglycerin have been used successfully to treat SS.


CONCLUSIONS
The SS is increasingly recognized and reported in the literature. Clinical and basic science research have increased our understanding of the pathophysiology, conditions, and agents that may predispose to the development of the syndrome. Newer treatment strategies are discussed.
Brown
T M
TM
Department of Psychiatry, WHMC/PSCCE, Wilford Hall Medical Center, Lackland Air Force Base, TX 78236, USA.
Skop
B P
BP
Mareth
T R
TR
D000818:Animals; D006801:Humans; D012701:Serotonin / Q000378:metabolism* / Q000502:physiology; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D013577:Syndrome
D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors